obesity drug news today glp-1 september 29 2025 Trump announces $50/month weight loss drugs for millions Alarming rise in weight loss
Description
[DOI] [PubMed] [Google Scholar] 5.Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, et al
2022;79(17):e263421
The Saxenda Spin-Off: Another Weight Management Star While Ozempic and Wegovy have garnered much attention, let's not forget another GLP-1 receptor agonist family member that's been turning heads in the weight management world for years now: Saxenda (liraglutide)
It acts as an incretin enhancer, meaning it does not directly force the pancreas to release insulin (like older sulfonylureas), but rather prolongs the life of natural hormones that signal insulin release only when blood sugar is actually elevated
Price & Trust Transparency Score: D Our Price & Trust Transparency Score is about total value, not hype
I was addicted to sugar
